NCT03448588

Brief Summary

As one of the essential micronutrients, selenium has important biological functions. However, an effective and convenient method for evaluation of selenium nutritional status has not yet been established. Previous literature has disclosed effect of selenium deficiency on inactivating glutathion peroxidase and deiodinase, which may cause decreased conversion from thyroxine ( T4) to triiodothyronine (T3). A case-control study is designed to demonstrate the association between selenium deficiency and abnormally elevated T4 or T4/T3, which may provide more clues for establishing effective selenium assesment methods.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 28, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

May 23, 2018

Status Verified

May 1, 2018

Enrollment Period

9 months

First QC Date

February 7, 2018

Last Update Submit

May 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • between-group difference in serum selenium

    comparison of the mean serum selenium between the two groups

    up to 24 weeks

Secondary Outcomes (2)

  • between-group difference in serum deiodinase activity

    up to 24 weeks

  • between-group difference in erythrocyte glutathione peroxidase activity

    up to 24 weeks

Study Arms (2)

group with normal T4 level or T4/T3

participants with T4 within 4.3-12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) ≤7.52, which are considered to be normal T4 level and T4/T3.

Diagnostic Test: detection of serum selenium

group with elevated T4 level or T4/T3

participants with T4 more than 12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) \> 7.52, which are considered to be elevated T4 level and T4/T3.

Diagnostic Test: detection of serum selenium

Interventions

For this case-control study, no intervention will be administered to participants, only serum sample will be collected for selenium assessment

group with elevated T4 level or T4/T3group with normal T4 level or T4/T3

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be recruited from volunteers who undergo health examination in Peking Union Medical College Hospital and meet the inclusion criteria.

You may qualify if:

  • with normal free triiodothyronine( FT3), free thyroxine (FT4) and thyroid-stimulating hormone (TSH).
  • without thyroid hormone replacement therapy
  • without medical history of thyroid surgery
  • without iodine radiotherapy;

You may not qualify if:

  • acute critical illness in the latest 1 year;
  • weight fluctuation by more than 5% in the latest 3 months;
  • eating disorders
  • neuropsychological disorders
  • allergy to corn or yeast
  • fail to give informed consents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dietitian

Study Record Dates

First Submitted

February 7, 2018

First Posted

February 28, 2018

Study Start

April 1, 2018

Primary Completion

December 31, 2018

Study Completion

April 1, 2019

Last Updated

May 23, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations